Eplerenone

Prescription ·Strong evidence ·Reviewed May 2026

Eplerenone is a selective mineralocorticoid receptor antagonist with significantly less anti-androgenic activity than spironolactone. The EPHESUS trial showed mortality reduction in post-MI patients with heart failure, and EMPHASIS-HF demonstrated benefit in mild heart failure (NYHA II). It is preferred over spironolactone when gynecomastia or sexual side effects are a concern.

What it's good for
  • Reduces mortality post-MI with HF (EPHESUS trial)6,8
  • Reduces CV death and HF hospitalization in mild HF (EMPHASIS-HF)7
  • Selective MR antagonism, much lower gynecomastia risk than spironolactone6
  • Potassium-sparing diuresis
What to watch for
  • Hyperkalemia (most important adverse effect)
  • Dizziness
  • Diarrhea
  • Serum potassium >5.0 mEq/L at initiation
  • CrCl <30 mL/min (or <50 mL/min when used for hypertension)4

The bottom line

Evidence rating strong. Most-documented uses: reduces mortality post-mi with hf (ephesus trial), reduces cv death and hf hospitalization in mild hf (emphasis-hf), selective mr antagonism, much lower gynecomastia risk than spironolactone. 10 sources indexed (2022–2026), with 1 interaction record on file.

The science

How it works, mechanistically.

Core mechanism

Selectively blocks the mineralocorticoid (aldosterone) receptor with ~500-fold lower affinity for androgen and progesterone receptors compared to spironolactone. Blocks aldosterone-mediated sodium reabsorption and potassium excretion in the collecting duct. In heart failure, prevents aldosterone-driven cardiac fibrosis, inflammation, and vascular remodeling. The selectivity accounts for the markedly lower rate of gynecomastia and sexual side effects.8,6

Class
Selective Mineralocorticoid Receptor Antagonist
Dosing

Dosing & protocol.

Common range
25–50 mg once daily (as prescribed by your physician)
Recommended form
Oral tablet

Can be taken with or without food; food does not significantly affect absorption

Safety

Full safety detail.

Side effects

  • Hyperkalemia (most important adverse effect)
  • Dizziness
  • Diarrhea
  • Cough
  • Fatigue
  • Hyponatremia

Contraindications

  • Serum potassium >5.0 mEq/L at initiation
  • CrCl <30 mL/min (or <50 mL/min when used for hypertension)4
  • Type 2 diabetes with microalbuminuria and serum creatinine >2.0 mg/dL (males) or >1.8 mg/dL (females)10
  • Concurrent strong CYP3A4 inhibitors (ketoconazole, itraconazole, nefazodone, clarithromycin, ritonavir)
  • Concurrent potassium supplements or potassium-sparing diuretics
Interactions

Interaction records.

DangerousConflict

Potassium

Eplerenone is a mineralocorticoid receptor antagonist that can raise serum potassium. Adding potassium supplements can push potassium into a dangerous range, especially in kidney disease, diabetes, heart failure, older age, or when ACE inhibitors, ARBs, NSAIDs, or trimethoprim are also used. Severe hyperkalemia can cause weakness, paralysis, dangerous arrhythmias, or cardiac arrest.

Recommendation: Do not take potassium supplements with eplerenone unless your prescriber specifically orders them and monitors potassium. Avoid potassium-based salt substitutes, and check potassium and kidney function shortly after starting or changing eplerenone.

Sources

Sources, by evidence tier.

Numbered references. Citations throughout the page link here.

Meta-analyses & systematic reviews

5
Keep exploring

Deep dives & adjacent profiles.

This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.

Use this with your stack

Eplerenone in NutriStack.

Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.